Drawing for PMORPH

USPTO serial 75873432

PMORPH

Reviewed by CopyMark Law Group

Reg. 2535483Status 710
Filing date
Status date
Registration date
Feb 5, 2002
Examiner
CASE, LEIGH CAROLINE
Law office
GENERIC WEB UPDATE

What this means

Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active. Evaluate filing a new application if you still use the mark, or petition if cancellation was erroneous. Consult counsel on remaining common-law rights.

Status 710: Status 710 means the registration was cancelled because a required Section 8 declaration of continued use was not filed within the deadline (including any grace period). The federal registration is no longer active.

Need help with PMORPH?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Michael J. Leonard

Michael J. Leonard Fox Rothschild LLP997 Lenox Drive, Building 3Lawrenceville, NJ 08648-2311UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
001chemical, biochemical, biological and biotechnological preparations, namely, recombinant vectors for cloning, manipulating, or expression of recombinant DNA for industrial and scientific use; biological preparations, namely, recombinant vectors for laboratories, diagnostics, and analytics for scientific or research use [ ; auxiliary preparations, carriers and substances for use in the manufacture of pharmaceutical preparations ]SECTION 8 - CANCELLED
005biological preparations, namely, recombinant vectors for cloning, manipulating, or expression of recombinant DNA for laboratories, diagnostics and analytics for human and veterinary medical diagnostic use; pharmaceutical and veterinary preparations and substances for the treatment of cancer, inflammatory diseases, Alzheimer, sepsis, restinosis, and other conditions which can be treated or ameliorated by antibodies binding to, or activation or blocking of, a target antigen; [ sanitary preparations for use in toothpaste or disinfectants; auxiliary preparations, carriers and substances sold as integral components of pharmaceutical preparations ]SECTION 8 - CANCELLED
042[ scientific, biological and medical research in the fields of analytical chemistry, biochemistry, medicinal chemistry, drug development, biotechnology, microbiology and molecular biology, chemical, biochemical and biotechnological analysis ]SECTION 8 - CANCELLED

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Aug 19, 2022CAEXCANCELLED SEC. 8 (10-YR)/EXPIRED SECTION 9
Feb 5, 2021REM2COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Feb 22, 2017CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Feb 22, 2017COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
May 30, 2013TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Feb 1, 2012NA89NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Feb 1, 2012RNL1REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)The trademark registration was renewed for another 10-year term after acceptable maintenance filings. RNL1, RNL2, and RNL3 indicate which renewal cycle (first, second, or third 10-year term) was recorded. The registration remains active.
Feb 1, 201289AGREGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTEDThe USPTO accepted your combined Section 8 declaration and Section 9 renewal application. The registration is renewed for another 10-year term. The next combined maintenance filing will be due at the following 10-year anniversary.
Jan 10, 2012E89RTEAS SECTION 8 & 9 RECEIVED
Apr 6, 2010TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jun 9, 2008C15PREGISTERED - PARTIAL SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
May 6, 2008PLGLASSIGNED TO PARALEGAL
Apr 22, 2008815FREGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Apr 22, 2008E815TEAS SECTION 8 & 15 RECEIVED
Apr 11, 2008ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Apr 11, 2008REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Apr 3, 2007CFITCASE FILE IN TICRS
Nov 23, 2002COC.CORRECTION UNDER SECTION 7 - PROCESSED
Sep 23, 2002COC.CORRECTION UNDER SECTION 7 - PROCESSED
Aug 1, 2002AMD7SEC 7 REQUEST FILED
Aug 1, 2002MAILPAPER RECEIVED
Feb 5, 2002R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Nov 13, 2001PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 24, 2001NPUBNOTICE OF PUBLICATION
May 23, 2001CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
May 4, 2001CNEAEXAMINER'S AMENDMENT MAILED
Dec 21, 2000CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Dec 21, 20001.BDSec. 1(B) CLAIM DELETED
Aug 2, 2000CNRTNON-FINAL ACTION MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jul 26, 2000DOCKASSIGNED TO EXAMINER
Jul 25, 2000DOCKASSIGNED TO EXAMINER

Frequently asked questions

Related guidance